Chargement en cours...
PURLs: How do these 3 diabetes agents compare in reducing mortality?
A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4 inhibitors.
Enregistré dans:
| Publié dans: | J Fam Pract |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontline Medical Communications Inc
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484967/ https://ncbi.nlm.nih.gov/pubmed/30870538 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|